Continuing Education Credits (CMEs and CEUs)
The deadline for submitting your accreditation application has passed. If you need assistance, please email email@example.com.
The American Society of Human Genetics (ASHG) Annual Meeting is a forum for the education of physicians in the field of genetics. By attending invited sessions, symposia, and plenary and platform presentation, the physicians will receive both a broad overview of the field and information about the most recent, detailed research on the topic of the session. By attending any of the activities, physicians will better understand the basic science that underlies clinical practice.
Statement of Need
It is important that physicians comprehend the basic science that underlies clinical medicine. The American Society of Human Genetics Annual Meeting is the premier venue for this educational opportunity. Physicians learn about the most up-to-date, cutting-edge discoveries regarding genetics.
Global Learning Objectives
All attendees obtaining CME/CEU credits will be able to apply the newly acquired knowledge and use of methods in the evaluation, diagnosis, intervention, treatment, and follow-up of patients with a variety of disorders.
At the conclusion of the ASHG2016 Annual Meeting participants should be able to:
- Identify and fill gaps in knowledge in human genetics in areas of statistical analysis, full genome sequencing, next generation sequencing, genetic neurodegenerative and other disorders, and epigenetics.
- Explain the value and use of newest technological methods in full genome sequencing in diagnosis of disorders and family studies.
- Provide context from discussions on the benefits and harms of returning results of full genome sequencing to patients.
- Set principles for the provision of results and their interpretation in full genome sequencing and the diagnosis of genetic risks.
- Accrue guidelines for the successful counseling of patients receiving complex genetic results.
- Present the newest results of gene therapy trials so clinicians may enroll patients or apply therapies to appropriate patients.
- Identify and explain the newest non-invasive prenatal diagnostic methods.
- Integrate results of genomic testing into electronic health records and other methods to store information.
- Recognize methods to utilize centralized databases in the diagnosis and treatment of patients.
This meeting is targeted to research scientists, clinical and laboratory practitioners, and others interested in the field of human genetics. The program is varied so that participants may select from several concurrent sessions those that fit their specialized research interests and clinical practice applications.
ASHG Annual Meeting attendees include:
- Laboratory geneticists, directors, technicians, and technologists
- Medical and clinical geneticists
- Physicians of all specialties with an interest in genetics, genomics, and the genetic basis of disease
- Genetic counselors
- Biotechnology and pharmaceutical development professionals
- Fellows, trainees, and students
In accordance with the Accreditation Council for Continuing Medical Education and the policy of the American Society of Human Genetics, before their presentations, all faculty, speakers and moderators must disclose the existence of any financial interest and/or other relationship(s) they might have with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) to be discussed during their presentation: receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received or expected. Disclosures will be included in the on-site Program Guide and in speakers' slide presentations.
CME, CEU, and P.A.C.E.® CEU credits may be reported by each attendee at the conclusion of the meeting via ASHG’s computerized self-reporting system. To apply for credits, please check the appropriate box on the registration form. A separate, nonrefundable fee is required.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Medical Genetics and Genomics and American Society of Human Genetics. The American College of Medical Genetics and Genomics is accredited by the ACCME to provide continuing medical education for physicians.
The American College of Medical Genetics and Genomics designates this live activity for a maximum of 29 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There is a nonrefundable $45 fee payable during the registration process. You can apply for credits through the online application available beginning Friday, October 21, 2016. The deadline to submit your request is Thursday, December 1, 2016. Attendees may use the mobile application or the Program-at-a-Glance to help track the sessions they attended. Please see the section below for the learning objectives, target audience, disclosure policy, and a list of presenters’ financial disclosures.
The American Board of Medical Genetics and Genomics (ABMGG) will accept CMEs for MDs, MD/PhDs, PhDs, or DOs participating in the Maintenance of Certification (MOC) program in any ABMGG specialty.
Clinical Content Validation
Accredited providers are responsible for validating the clinical content of CME activities that they provide. Specifically,
1. All the recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
2. All scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design,data collection and analysis.
3. Providers are not eligible for ACCME accreditation or reaccreditation if they present activities that promote recommendations, treatment, or manners of practicing medicine that are not within the definition of CME, or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients. An organization whose program of CME is devoted to advocacy of unscientific modalities of diagnosis or therapy is not eligible to apply for ACCME accreditation.
HIPAA Compliance by Speakers
The ASHG supports medical information privacy. While the ASHG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ASHG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ASHG-sponsored events has been properly authorized. All presenters have completed a form indicating whether they intend to present any form of individually identifiable healthcare information. If so, they were asked either to attest that a HIPAA-compliant consent form is on file at their institution, or to send ASHG a copy of the ASHG HIPAA compliance form.
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of ACMG.
Off-Label or Unapproved Use of Drugs or Devices
It is the policy of the ASHG to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Continuing Education Unit Credits (CEUs) for Genetic Counselors
National Society of Genetic Counselors (NSGC) designates this live activity for a maximum of 2.90 Category 1 CEU (29.0 contact hours). NSGC is approved as an authorized provider of continuing education and training by the International Association for Continuing Education and Training (IACET).
There is a nonrefundable $35 fee payable during the registration process($25 of the fee is payable to NSGC. $10 covers ASHG administrative fees). You can apply for credits through the online application available beginning Friday, October 21, 2016. The deadline to submit your request is Thursday, December 1, 2016. Attendees may use the mobile application or the Program-at-a-Glance to help track the sessions they attended. Please see the section below for the learning objectives, target audience, disclosure policy, and a list of presenters’ financial disclosures.
Genetic Counselors and Nurses should apply for CEUs. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of certification and recertification.
Continuing Education Unit Credits (CEUs) for California-Licensed Clinical and Molecular Laboratory Directors (P.A.C.E.®)
Professional Acknowledgment for Continuing Education (P.A.C.E.®) program for California-Licensed Clinical and Molecular Laboratory Directors designates this live
activity for a maximum 28.0 CEU credits.
There is a nonrefundable $35 fee payable during the registration process. You will need to pick up your CEU packet in the ASHG Meeting Office, Room 116.You can apply for credits through the online application available beginning Friday, October 21, 2016. The deadline to submit your request is Thursday, December 1, 2016. Attendees may use the mobile application or the Program-at-a-Glance to help track the sessions they attended. Please see the section below for the learning objectives, target audience, disclosure policy, and a list of presenters’ financial disclosures.
Clinical Laboratory Scientists should apply for P.A.C.E. CEUs. ABMGG will accept P.A.C.E. CEUs for diplomats participating in the MOC program in the following categories: Clinical Biochemical Geneticist, Clinical Cytogeneticist, and Clinical Molecular Geneticist.